| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC1153 |
| Trial ID | NCT00003257 |
| Disease | Head and Neck Cancer |
| Altered gene | P53 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | AdV5.CMV-p53 |
| Phase | Phase2 |
| Recruitment status | Unknown |
| Title | A Phase II, Multicenter, Open Label Study to Evaluate Effectiveness and Safety of AdCMV-p53 Administered by Intra-Tumoral Injections in 39 Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) |
| Year | 1999 |
| Country | United States |
| Company sponsor | Aventis Pharmaceuticals |
| Other ID(s) | CDR0000066148|AVENTIS-T-202|MCC-11653|RP-T-202|NCI-V98-1394 |
| Vector information | |||||||||||||
|
|||||||||||||
| Cohort 1 | |||||||||
|
|||||||||